Medtronic Balance Sheet Health

Financial Health criteria checks 5/6

Medtronic has a total shareholder equity of $52.0B and total debt of $25.1B, which brings its debt-to-equity ratio to 48.3%. Its total assets and total liabilities are $90.8B and $38.8B respectively. Medtronic's EBIT is $6.3B making its interest coverage ratio 46.4. It has cash and short-term investments of $8.3B.

Key information

48.3%

Debt to equity ratio

US$25.13b

Debt

Interest coverage ratio46.4x
CashUS$8.32b
EquityUS$52.00b
Total liabilitiesUS$38.84b
Total assetsUS$90.84b

Recent financial health updates

Recent updates

35% Undervalued? Medtronic's Future Looks Very Bright

Apr 12

Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now

Mar 27

Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth

Mar 11

Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Mar 11
Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Medtronic: Its Recent Beat Proves That It Continues To Be A Rock

Feb 25

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 22
Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility

Feb 16

A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Jan 31
A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Jan 16
Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Medtronic Stock's Rally Is Set To Continue

Jan 11

Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Dec 29
Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Dec 12
Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Medtronic: The GLP-1 Drug Headwinds Are Overblown

Dec 10

3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic

Nov 28

Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Nov 19
Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings

Nov 17

Medtronic Faces Potential Decline Despite Financial Strength

Oct 29

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Oct 19
An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Oct 04
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%

Sep 27

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Sep 18
Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Medtronic: The Tide Is Turning

Aug 24

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Aug 21
Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Medtronic: Dark Clouds Are Clearing - Outperformance Ahead

Aug 14

Return Trends At Medtronic (NYSE:MDT) Aren't Appealing

Aug 11
Return Trends At Medtronic (NYSE:MDT) Aren't Appealing

Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth

Jul 15

Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?

Jul 09
Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?

Is Medtronic (NYSE:MDT) A Risky Investment?

Jun 21
Is Medtronic (NYSE:MDT) A Risky Investment?

Medtronic: Weak Forecasts Spoiled Strong Results For The Reporting Quarter

Jun 21

Is Medtronic's Dividend In A Good Place?

Jun 14

Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69

Jun 03
Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69

Medtronic: Solid Q4 Earnings, Don't Fret About Guidance

May 26

Investors Met With Slowing Returns on Capital At Medtronic (NYSE:MDT)

May 04
Investors Met With Slowing Returns on Capital At Medtronic (NYSE:MDT)

Does This Valuation Of Medtronic plc (NYSE:MDT) Imply Investors Are Overpaying?

Mar 10
Does This Valuation Of Medtronic plc (NYSE:MDT) Imply Investors Are Overpaying?

Where Will Medtronic Stock Be In 4 Years?

Feb 17

Medtronic: A Trend Change May Be Underway Ahead Of Earnings

Feb 06

Medtronic recalls ~23K Mahurkar hemodialysis catheters

Jan 30

Financial Position Analysis

Short Term Liabilities: MDT's short term assets ($22.5B) exceed its short term liabilities ($9.8B).

Long Term Liabilities: MDT's short term assets ($22.5B) do not cover its long term liabilities ($29.0B).


Debt to Equity History and Analysis

Debt Level: MDT's net debt to equity ratio (32.3%) is considered satisfactory.

Reducing Debt: MDT's debt to equity ratio has reduced from 50.1% to 48.3% over the past 5 years.

Debt Coverage: MDT's debt is well covered by operating cash flow (25.8%).

Interest Coverage: MDT's interest payments on its debt are well covered by EBIT (46.4x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.